CNS Biomarkers

CNS biomarkers are measurable indicators that provide insights into the diagnosis, progression, and treatment of central nervous system disorders. These biomarkers, derived from imaging, cerebrospinal fluid, blood, or genetics, help detect conditions like Alzheimer's, multiple sclerosis, and Parkinson's at early stages. Advances in biomarker research enable precision medicine, guiding targeted therapies and monitoring treatment responses. By enhancing understanding of disease mechanisms, CNS biomarkers play a critical role in revolutionizing neurological care and improving patient outcomes.

 

    Related Conference of CNS Biomarkers

    November 22-23, 2024

    4th International Conference on Medical Research and Development

    Aix-en-Provence, France
    November 25-26, 2024

    10th World Congress on Anesthesia and Critical Care

    Paris, France
    April 16-17, 2025

    9th International Conference on Internal Medicine

    Berlin, Germany
    May 12-13, 2025

    19th International Conference on Obesity Medicine

    Toronto, Canada
    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    July 16-17, 2025

    11th World Congress on Medicinal Plants and Marine Drugs

    Aix-en-Provence, France
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Paris, France

    CNS Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in